Hope for this and many other diseases is fueled by a United Kingdom researcher who is trying to develop delivery systems that bypass these faulty cell membrane proteins to properly orchestrate the ...

Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...

Zeiss has unveiled the new Zeiss Crossbeam 750 focused ion beam-scanning electron microscope (FIB-SEM), optimised for demanding sample preparation. It can provide a live, high-resolution “see while ...

Respiratory syncytial virus (RSV) is a highly contagious, seasonal pathogen and a leading global cause of acute lower respiratory infections (ALRIs). Globally, RSV is responsible for an immense health ...

Life science company Amsbio has launched a range of authenticated cell lines covering a range of tumours and tissues. The addition offers over 1,000 independently verified cell lines and versatile ...

A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...

Imaging CRO Qureight will use its end-to-end imaging technology and services in a clinical trial analysing diffuse cutaneous Systemic Sclerosis (dcSSc). SSc is a complex disease characterised by ...

Recombinant technology specialist Sino Biological has launched the XPressMAX Cell-Free Protein Synthesis Kit (Cat#: CFKIT02). The solution is designed to supercharge AI-driven high-throughput ...

Servier, an independent international pharmaceutical company governed by a foundation, and n-Lorem Foundation, a non-profit organisation established to provide experimental medicines to patients with ...

Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...

Organoids, or miniature organ-like structures derived from stem cells, have emerged as transformative tools in biomedical research. Unlike traditional two-dimensional (2D) cell cultures, organoids ...

Independent European studies presented at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 and Alzheimer’s & Parkinson’s Disease Conference (ADPD) 2026 confirmed that the HISCL p-Tau217 RUO and ...